Diabetes and Sexual Health

Why Diabetes and Sexual Health Are Deeply Connected

Sexual dysfunction is among the most common — and most underreported — complications of diabetes. Studies estimate that erectile dysfunction affects 35–90% of men with diabetes (compared to approximately 25% of men without diabetes in the same age groups), and sexual dysfunction in women with diabetes — including reduced arousal, vaginal dryness, difficulty with orgasm, and painful intercourse — is similarly prevalent, affecting 25–50% of women with long-standing diabetes. Despite this prevalence, sexual health is rarely discussed proactively in diabetes clinic visits: surveys show that only about one-third of people with diabetes who have sexual health concerns bring them up with their healthcare provider, and a similar minority of providers ask about them. The result is that one of the most quality-of-life-impairing complications of diabetes goes largely unaddressed. Our guide on what is diabetes provides foundational context; this article covers the full scope of diabetes and sexual health — causes, types of dysfunction in men and women, and evidence-based treatment options.

Sexual response in both men and women depends on the integrated function of the vascular system (blood flow to genital tissues), the nervous system (autonomic and somatic signals coordinating arousal and orgasm), the hormonal environment (testosterone, estrogen, prolactin), and the psychological dimension (desire, body image, relationship satisfaction, anxiety). Diabetes can impair all four systems simultaneously through its effects on small blood vessels, peripheral and autonomic nerves, hormone regulation, and psychological wellbeing. This is why sexual dysfunction in diabetes tends to be more complex, more severe, and less responsive to single-mechanism treatments than erectile dysfunction in otherwise healthy men without diabetes.

The Hidden Burden of Sexual Dysfunction in Diabetes Despite affecting the majority of men with long-standing diabetes and a large proportion of women, sexual health complications are among the least discussed aspects of diabetes care. Studies show that healthcare providers ask about sexual function in fewer than 20% of diabetes visits. Patients are often reluctant to raise the topic — citing embarrassment, assuming it is an inevitable consequence of aging or diabetes, or not knowing that effective treatments exist. The reality is that for many people with diabetes, sexual dysfunction has a greater day-to-day impact on quality of life and relationship satisfaction than the pain of neuropathy or the inconvenience of insulin injections — and effective treatments are available for both men and women.

Erectile Dysfunction in Men With Diabetes

Erectile dysfunction (ED) — the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity — occurs approximately 10–15 years earlier in men with diabetes than in men without diabetes, and is more severe and more treatment-resistant. The pathophysiology of diabetic ED involves three overlapping mechanisms:

Vascular Mechanism

Penile erection is a vascular event: sexual arousal triggers release of nitric oxide (NO) from endothelial cells in penile blood vessels, causing smooth muscle relaxation and vasodilation that fills the corpus cavernosum with blood. Diabetes impairs endothelial function, reducing NO availability through oxidative stress, AGE accumulation in vessel walls, and atherosclerosis of the pudendal and cavernous arteries. The result is impaired arterial inflow and failure to achieve adequate intracavernosal pressure for erection. Diabetes-related ED is, in this sense, a form of cardiovascular disease in the penis — and the presence of ED in a diabetic man is now recognized as a cardiovascular risk marker, similar to erectile dysfunction in men without diabetes predicting future coronary artery disease. Our guide on diabetes and heart disease covers the shared vascular mechanisms underlying both ED and coronary artery disease in diabetes.

Neurogenic Mechanism

Autonomic neuropathy damages the cavernous nerves that coordinate the neural reflex of erection — the parasympathetic fibers from S2-S4 that trigger NO release in response to sexual stimulation. When these nerves are damaged, the neurogenic component of erection is impaired, producing ED that is resistant to PDE5 inhibitors (which potentiate the NO signal but require intact neural NO release to work). Our guide on diabetes and nerve damage covers the autonomic neuropathy that affects cavernous nerve function alongside its other clinical manifestations.

Hormonal Mechanism

Hypogonadism (low testosterone) is significantly more common in men with Type 2 diabetes and obesity than in the general male population — affecting approximately 25–40% of men with Type 2 diabetes. Insulin resistance and obesity suppress the hypothalamic-pituitary-gonadal axis, reducing luteinizing hormone (LH) release and consequently testosterone production. Low testosterone reduces libido, impairs erectile function independently of vascular and neural mechanisms, causes fatigue and depression, and worsens insulin resistance — creating a cycle in which low testosterone contributes to worse metabolic control. Testosterone measurement (total and free testosterone, preferably morning fasting) should be part of the evaluation of ED in men with diabetes.

medical diagram showing how diabetic neuropathy and vascular disease cause erectile dysfunction in men with diabetes — Erectile dysfunction in diabetes results from the combined effects of endothelial dysfunction reducing nitric oxide availability for penile smooth muscle relaxation, autonomic neuropathy disrupting the neural reflexes needed for erection, and reduced testosterone from hypogonadism common in Type 2 diabetes.

Treatment of Erectile Dysfunction in Diabetic Men

Treatment of ED in men with diabetes follows a stepwise approach from least to most invasive:

Blood glucose and cardiovascular risk factor optimization: Improving HbA1c, blood pressure, and lipid control improves endothelial function and may modestly improve ED, while also reducing overall cardiovascular risk. Weight loss in men with obesity and Type 2 diabetes has been associated with improved testosterone levels and erectile function. Our guide on diabetes and cholesterol covers lipid management that benefits both cardiovascular and erectile health.
PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil): First-line pharmacotherapy for ED in diabetes. These medications enhance the NO-mediated smooth muscle relaxation of penile vessels by blocking phosphodiesterase-5, which breaks down cyclic GMP (the second messenger of NO signaling). Response rates in diabetic men are lower (40–60%) than in non-diabetic men (70–85%) because the NO signal they potentiate is already impaired by diabetes. Tadalafil taken daily (5 mg) rather than on-demand may provide better results in diabetic ED by maintaining continuous PDE5 inhibition. PDE5 inhibitors are contraindicated with nitrate medications and should be used cautiously with alpha-blockers. Men with severe cardiovascular disease should have cardiac risk cleared before resuming sexual activity.
Testosterone replacement therapy: For men with confirmed hypogonadism (total testosterone below 300 ng/dL with consistent symptoms), testosterone replacement (injectable, transdermal gel, or pellet) improves libido, energy, and mood, and may modestly improve response to PDE5 inhibitors. Testosterone therapy requires monitoring of hematocrit, PSA, and testicular atrophy, and is contraindicated in men with prostate or breast cancer.
Vacuum erection devices: Mechanical devices that create negative pressure around the penis to draw blood in, followed by a constriction ring to maintain erection. Effective and safe without systemic medication effects, making them useful for men who cannot take PDE5 inhibitors or who have not responded to them.
Penile prosthesis: Surgically implanted inflatable or malleable devices that allow men to achieve an erection at will. Reserved for men with refractory ED who have failed all other treatments, penile prostheses have high patient and partner satisfaction rates. In men with diabetes, surgical infection risk is higher, requiring meticulous antibiotic prophylaxis and perioperative blood glucose management.

Sexual Dysfunction in Women With Diabetes

Sexual health complications in women with diabetes are at least as prevalent as in men but receive substantially less research attention and clinical recognition. The ADA explicitly recommends screening women with diabetes for sexual dysfunction, yet this rarely happens in clinical practice. Sexual dysfunction in diabetic women includes:

Reduced sexual desire (hypoactive sexual desire disorder): Chronic illness, fatigue, pain (from neuropathy), body image concerns, and depression — all more prevalent in women with diabetes — reduce libido independently of any vascular or hormonal mechanism. Psychological factors are a major contributor to sexual dysfunction in women with diabetes and should not be overlooked in evaluation and treatment.
Reduced vaginal lubrication and arousal: Vaginal lubrication is a vascular response to sexual arousal analogous to penile erection — blood flow to the vaginal wall transudates fluid that lubricates the vaginal epithelium. Endothelial dysfunction and autonomic neuropathy impair this process in women with diabetes, causing inadequate lubrication that leads to dyspareunia (painful intercourse) and reduced arousal.
Difficulty achieving orgasm (anorgasmia): Autonomic and somatic neuropathy affecting the pelvic nerves reduces orgasmic intensity or prevents orgasm entirely. This mechanism is analogous to the neuropathic contribution to ED in men.
Vaginal atrophy and dryness in postmenopausal women: Postmenopausal women with diabetes experience estrogen deficiency-related vaginal atrophy at the same rate as women without diabetes, but the combination of atrophic changes and diabetic autonomic neuropathy produces more severe sexual dysfunction than either condition alone.
Recurrent vaginal infections: As noted in the oral health section, elevated vaginal glucose (from glycosuria) and impaired local immunity create frequent vaginal Candida infections that cause pain, discharge, and disruption of sexual activity.

Treatment options for women with diabetes and sexual dysfunction include water-based or silicone lubricants for vaginal dryness, vaginal estrogen preparations (local estrogen with minimal systemic absorption for postmenopausal women — generally safe even in women with cardiovascular disease), pelvic floor physiotherapy for dyspareunia and orgasmic dysfunction, and psychological therapy (individual or couples therapy) for desire and psychological dimensions of sexual dysfunction. Flibanserin (Addyi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women, though its effect size is modest and it carries interaction risks with alcohol and CYP3A4 inhibitors. Our guide on diabetes in women: signs and risk factors covers the gender-specific aspects of diabetes that inform sexual health evaluation and management.

Urological Complications of Diabetes Beyond Erectile Dysfunction

Diabetes affects the urinary system through many of the same neuropathic and vascular mechanisms that affect sexual function. These urological complications frequently co-occur with ED and female sexual dysfunction, forming a cluster of pelvic autonomic neuropathy manifestations:

Diabetic Cystopathy (Neurogenic Bladder)

Autonomic neuropathy affecting the bladder (diabetic cystopathy) progresses through predictable stages. First, bladder sensation is reduced — the normal urge to urinate at 200–300 mL of bladder filling is diminished, causing people to urinate infrequently and allow the bladder to overfill. Over time, the detrusor muscle (bladder wall muscle) that contracts to expel urine becomes impaired, causing incomplete bladder emptying and urinary retention. The residual urine left in the bladder after voiding creates a reservoir for bacterial growth — dramatically increasing urinary tract infection risk. In women with diabetes, UTIs are both more frequent and more likely to be complicated (ascending to the kidneys or caused by antibiotic-resistant organisms) than in women without diabetes. In men, the combination of diabetic cystopathy and age-related benign prostatic hyperplasia (BPH) can produce severe urinary obstruction requiring urological intervention. Management of diabetic cystopathy includes scheduled urination (voiding every 3–4 hours regardless of urge), double voiding (attempting a second void shortly after the first to empty the bladder more completely), and in severe cases, intermittent self-catheterization or alpha-1 blocker medications to reduce outlet resistance. Our guide on diabetes and nerve damage covers the autonomic neuropathy framework within which diabetic cystopathy develops.

Overactive Bladder and Urge Incontinence

While retention is the classic diabetic cystopathy presentation, some people with diabetes develop overactive bladder (OAB) — characterized by sudden, urgent, uncontrollable urges to urinate, often resulting in urge incontinence (leaking before reaching the toilet). OAB in people with diabetes is driven by a different mechanism: detrusor overactivity from abnormal excitatory neural signaling in a bladder that has lost its normal inhibitory control. Women with diabetes have significantly higher rates of urinary incontinence than women without diabetes, and this has a profound impact on quality of life, social participation, and sexual intimacy. First-line treatment of OAB includes bladder training (scheduled voiding with gradually extended intervals), pelvic floor exercises, and if needed, anticholinergic medications (oxybutynin, solifenacin) — though these must be used cautiously in people with diabetes and autonomic neuropathy, as their anticholinergic effects can worsen bladder emptying and cause dry mouth, constipation, and cognitive effects particularly in older adults.

The Role of Blood Glucose Control in Sexual and Urological Health

The degree of glycemic control is one of the strongest predictors of sexual function in men and women with diabetes. Studies consistently show that higher HbA1c is associated with more severe ED, more pronounced female sexual dysfunction, worse diabetic cystopathy, and greater frequency of genital infections. Conversely, improvements in glycemic control — whether through lifestyle intervention, medication adjustment, or bariatric surgery — are associated with improvements in sexual function, particularly in younger men and women where vascular and neural damage is less established.

The mechanisms by which better blood glucose control improves sexual function include:

Improved endothelial function: Lower blood glucose reduces oxidative stress and AGE accumulation in penile and vaginal blood vessels, restoring nitric oxide bioavailability and improving vascular responses to sexual arousal
Reduced autonomic neuropathy progression: Intensive blood glucose control — as demonstrated in the DCCT trial for Type 1 diabetes — reduces the development and progression of autonomic neuropathy, thereby protecting cavernous nerve function and pelvic autonomic reflexes
Improved testosterone levels: Weight loss and improved insulin sensitivity in men with Type 2 diabetes often produce meaningful increases in testosterone — sometimes returning levels to the normal range without testosterone replacement
Reduced genital infections: Lower blood glucose reduces urinary and genital glucose concentrations, depriving Candida of its preferred substrate and reducing recurrent genital infections that disrupt sexual activity

For people with significant sexual dysfunction related to diabetes, addressing blood glucose control should be the first intervention — not because it will reverse established vascular and neural damage in older patients, but because it will maximize the effectiveness of all other treatments and prevent further deterioration. Our guides on Type 2 diabetes: causes and diagnosis and diabetes and high blood pressure cover the comprehensive metabolic management that forms the foundation of sexual and urological health protection in diabetes.

Talking to Your Healthcare Provider About Sexual Health

One of the most important — and most actionable — aspects of diabetes and sexual health management is simply breaking the silence around these issues in clinical visits. Research shows that when healthcare providers ask proactively about sexual function, patients are far more likely to disclose problems and benefit from treatment than when they must raise the topic themselves. People with diabetes who have sexual health concerns but haven’t discussed them with their provider might consider the following approach:

Prepare for the conversation: Write down specific symptoms — when they started, how frequently they occur, how much they bother you, and whether a partner is affected — before the appointment. This makes the conversation more efficient and ensures important details are communicated.
Frame it as a diabetes complication: “I’ve been reading that sexual difficulties are common in diabetes and I’ve been experiencing some of this” is an effective way to open the topic that normalizes the concern and contextualizes it within the diabetes care conversation.
Ask about screening: The ADA recommends that sexual function be assessed in all adults with diabetes. If your provider hasn’t asked, it is entirely appropriate to ask “Should we include sexual health as part of my diabetes monitoring?”
Bring a partner if appropriate: Sexual dysfunction affects both partners. When a partner is present for part of the clinical conversation, it can improve understanding of the problem’s impact, facilitate treatment decisions (particularly for ED treatment where partner preferences influence treatment choice), and support adherence to therapy.

Healthcare providers who specialize in diabetes-related sexual dysfunction include urologists and andrologists (for men) and urogynecologists or sexual medicine specialists (for women). Sex therapists and psychologists with expertise in chronic illness-related sexual dysfunction provide the psychological dimension of care. In academic medical centers, dedicated sexual health clinics for people with diabetes increasingly exist as part of comprehensive diabetes complication programs. Our guide on diabetes and mental health covers the depression and anxiety that frequently co-occur with sexual dysfunction in diabetes and that must be addressed alongside the physical aspects for treatment to succeed.

Sexual Health Is Part of Diabetes Care Sexual health is explicitly included in the American Diabetes Association’s Standards of Medical Care in Diabetes as a complication to be assessed and managed — not a peripheral concern. The evidence base for effective treatments (PDE5 inhibitors, testosterone replacement, local estrogen, lubricants, pelvic floor therapy, psychological counseling) is strong. The main barrier is not treatment availability but conversation avoidance — on both sides of the clinician-patient relationship. People with diabetes who are experiencing sexual health challenges deserve the same evidence-based, systematic approach to evaluation and treatment that retinopathy, nephropathy, or neuropathy receives. If your healthcare team hasn’t addressed sexual health in the context of your diabetes care, it is entirely appropriate to raise it — and entirely appropriate to expect a thoughtful, non-judgmental response.

Lifestyle Factors That Protect Sexual Health in Diabetes

Beyond medication, several modifiable lifestyle factors significantly influence sexual function in people with diabetes — and have the advantage of simultaneously improving overall diabetes management:

Regular aerobic exercise: Exercise improves endothelial function, raises testosterone in men with low levels, reduces depression and anxiety, improves body image, and enhances blood flow throughout the body including genital tissues. Studies in men with Type 2 diabetes show that 12 weeks of moderate aerobic exercise significantly improves erectile function scores, independent of changes in blood glucose. Our guide on sedentary lifestyle and blood sugar covers the metabolic benefits of regular physical activity that extend to sexual health protection.
Smoking cessation: Smoking dramatically accelerates atherosclerosis of penile blood vessels and is one of the strongest independent risk factors for ED. In men who smoke and have diabetes — a combination that multiplies vascular damage risk — smoking cessation is the single most important modifiable risk factor intervention for ED prevention, ahead of even improved glucose control in younger men with early vascular disease.
Alcohol moderation: Chronic heavy alcohol use damages peripheral nerves and reduces testosterone, compounding the neuropathic and hormonal contributions to sexual dysfunction in diabetes. Moderate alcohol intake (up to one drink per day for women, two for men) does not appear to worsen sexual function, but heavy use clearly does.
Weight management: Obesity reduces testosterone in men, impairs pelvic blood flow, causes sleep apnea (which lowers testosterone and causes fatigue), and worsens insulin resistance — all contributing to sexual dysfunction. Studies of bariatric surgery in obese men with Type 2 diabetes show remarkable improvements in erectile function and testosterone levels that occur within months of surgery, largely through testosterone normalization rather than improved neural or vascular function.

Sources: American Diabetes Association. “Standards of Medical Care in Diabetes.” Diabetes Care 2024. | NIDDK — Sexual and Urologic Problems of Diabetes. | Mayo Clinic — Erectile Dysfunction and Diabetes. | International Society for Sexual Medicine — ED and Diabetes. | Maiorino MI, et al. “Diabetes and Sexual Dysfunction: Current Perspectives.” Diabetes, Metabolic Syndrome and Obesity 2014.